ACP3 and prostate carcinoma: Although serum ACPP can be used to monitor prostate cancer it is reportedly not expressed in bladder cancer [36] and is not likely be a good biomarker for bladder cancer (because urinary ACPP may be primarily derived from the prostate) unless a genuinely bladder cancer specific glycoform exists.